对卡波地水痘样皮疹患者服用法姆昔洛韦(法姆韦®250毫克)的有效性和安全性的讨论(特定使用结果调查)

{"title":"对卡波地水痘样皮疹患者服用法姆昔洛韦(法姆韦®250毫克)的有效性和安全性的讨论(特定使用结果调查)","authors":"大輔 渡辺, 寿雄 吉田, 敏彦 新郷, 遥 竹田, 圭吾 中村, 毅 可児, 安繋 舛永","doi":"10.3812/JOCD.33.372","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":17355,"journal":{"name":"Journal of The Japan Organization of Clinical Dermatologists","volume":"81 1","pages":"372-382"},"PeriodicalIF":0.0000,"publicationDate":"2016-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"カポジ水痘様発疹症患者に対するファムシクロビル（ファムビル®錠250mg）の有効性および安全性の検討（特定使用成績調査）\",\"authors\":\"大輔 渡辺, 寿雄 吉田, 敏彦 新郷, 遥 竹田, 圭吾 中村, 毅 可児, 安繋 舛永\",\"doi\":\"10.3812/JOCD.33.372\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":17355,\"journal\":{\"name\":\"Journal of The Japan Organization of Clinical Dermatologists\",\"volume\":\"81 1\",\"pages\":\"372-382\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2016-04-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of The Japan Organization of Clinical Dermatologists\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3812/JOCD.33.372\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of The Japan Organization of Clinical Dermatologists","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3812/JOCD.33.372","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}